缩在神经退行性疾病中的作用
Manoj Govindarajulu1, Sindhu Ramesh1, Tharanth Shankar2
1Department of Drug Discovery and Development, Auburn University Harrison School of Pharmacy, Auburn, AL 36849, USA.
NeuroSci
|November 1, 2024
概括
蛋白质修饰过程的化对于清除神经退行性疾病中涉及的错误折叠蛋白质至关重要. 向缩通路为开发这些疾病的新疗法提供了一个有希望的途径.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 神经退行性疾病涉及渐进的神经元损失,通常与错误折叠的蛋白质积累有关.
- 蛋白质平衡至关重要,其破坏有助于神经元死亡.
- 化,一种类似于无处不在的过程,调节蛋白质清除.
研究的目的:
- 审查在神经退行性疾病中化通路的作用.
- 探索作为潜在的治疗点的缩信号.
主要方法:
- 关于化机制及其与神经退行症的联系的文献综述.
- 在疾病模型中分析目前关于化通路的研究.
- 综合了针对缩的治疗潜力的研究结果.
主要成果:
- 功能失调的缩与各种神经退行性疾病的发病有关.
- 缩对于清除错误折叠的蛋白质至关重要,这是神经元死亡的关键因素.
- 目前正在研究特定的化途径,以确定它们对疾病进展的贡献.
结论:
- 化通过管理蛋白质质量控制,在维持神经元健康方面发挥着至关重要的作用.
- 向缩途径为神经退行性疾病提供了一个新的治疗策略.
- 对缩信号的进一步研究可能会打开新的药物开发机会.
相关概念视频
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Parkinson's Disease: Overview
483
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
483
Nuclear Export of mRNA
7.6K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.6K
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
RNA Editing
8.9K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.9K


